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Editorial on the Research Topic
Glial and Neural Stem Cells as New Therapeutic Targets for Neurodegenerative Disorders
The gradual and progressive degeneration of neural cells is a common feature of different
neurological disorders culminating in a disturbed neuronal communication. The remarkable
discovery that adult brain has the capacity to develop new neurons, as well as new glial cells,
raised the hope to restore neuronal communication. It is now accepted that adult neurogenesis
occurs in neurogenic niches which are under the control of several factors including neurotrophins.
These neurogenic niches contain multipotent neural stem/progenitor cells (NSPCs) which
can differentiate into neurons, astrocytes and oligodendrocytes. Interestingly, different brain
injuries or pathologies, such as epilepsy, head traumas and stroke, induce neurogenesis and/or
astrogliogenesis. This increase in neurogenesis has been proposed as an endogenous attempt to
repair and reduce brain damage. On the contrary, aging and several neurodegenerative disorders
promote a decrease in neurogenesis. Nevertheless, NSPC-based therapy is, to date, not yet a
satisfactory strategy due to poor survival and differentiation levels, as well as reduced synaptic
plasticity either after transplantation or neural injury. Therefore, it is important to study the
molecular and cellular mechanisms of NSPC’s function in detail, and their potential therapeutic
applicability to improve long-term survival, differentiation, and synaptic integration of derived
newborn neural cells.
Classically, the studies in neurodegenerative disorders are mainly focused on neuronal
abnormalities, while the non-neuronal cells were almost neglected. Nevertheless, there is
increasing evidence that glial cells, and in particularly astrocytes and microglia, are very
important in the pathology of these disorders. Astrocytes play important roles in neuronal
synaptic activity by removing the majority of glutamate present at the synapse and also by
releasing modulators/transmitters that interact with neuronal receptors. Moreover, in pathological
conditions astrocytes have been implicated in the onset and progression of several diseases with
reactive astrogliosis a common feature. In many neurodegenerative disorders, several changes
in astrocytic function have been detected, namely in calcium signaling and in the release of
inflammatory molecules. Furthermore, microglia plays an important role in managing neuronal
cell death, neurogenesis, and synaptic interactions, besides their involvement in immune-response
generating cytokines. Most likely astrocytes and microglia are possible candidates as new
pharmacological targets that can ameliorate some of the features of neurological disorders.
This Research Topic containing 10 manuscripts highlights the role of glial and NSPCs in
physiological and pathological conditions. La Rosa et al. showed that enhancing the expression and
Xapelli et al. New Therapeutic Targets for Neurodegenerative Disorders
activity of the antioxidant response the master regulator
nuclear factor erythroid 2–related factor 2 ameliorates the
phenotypic defects observed in NSPCs, re-establishing a
proper differentiation program. Lauro et al. reported that
the chemokine CX3CL1 (fractalkine) protects against cerebral
ischemia modulating the activation state of microglia and its
metabolism in order to restrain inflammation and organize
a neuroprotective response against the ischemic insult. The
mini-review by Peteri et al. discussed that species-specificity
of astrocytes poses a challenge in translating results obtained
from animal studies to humans, and patient-derived induced
pluripotent stem cells offer an alternative to disease modeling.
The data described by Pereira de Melo Guimarães et al.
revealed that neurogenin 2 induces lineage conversion of
postnatal rodent müller glia cells into retinal ganglion cell-
like induced neurons in vitro and resumes the generation of
this neuronal type from late progenitors of the retina in vivo.
Ferreira et al. described an interaction between brain-derived
neurotrophic factor and endocannabinoid signaling in the
control of neurogenesis at distinct levels, further contributing to
highlight novel mechanisms in the emerging field of brain repair.
In the review by Casares-Crespo et al. the role of basal autophagy
in adult neural stem cells and neurogenesis was discussed.
Bribian et al. detailed the clonal glial response in a multiple
sclerosis mouse model. Pan et al. provided data showing that
small molecule (Methyl 3,4-dihydroxybenzoate) promotes NSCs
differentiation into cholinergic motor neurons by regulating
cell cycle and the cholinergic neuronal differentiation Isl1 gene.
Zhang et al. reviewed the relationship between microglia and
depression, elucidating the mechanism by which microglia
regulate inflammation and neurogenesis in response to major
depression disorder. Gonzalez-Perez et al. showed that tactile
inputs from vibrissal follicles strongly modify the expression of
c-Fos and calbindin in the dentate gyrus, disrupt different aspects
of hippocampal neurogenesis, and support the notion that spatial
memory and navigation skills strongly require tactile information
in the hippocampus.
Overall, the outstanding manuscripts including both reviews
and original articles of this Research Topic provide evidence
for a role of glial cells, namely microglia and astrocytes, and
NSPCs in physiological and pathological conditions. The study
of glial cells and NSPCs will continue to reveal novel and effective
therapeutic mechanisms for disorders of the nervous system. We
hope that this collection of articles will be highly attractive to the
neuroscience community.
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